Trial Profile
An open-label observational study of tiotropium bromide and olodaterol combination in patients with COPD
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jan 2017
Price :
$35
*
At a glance
- Drugs Olodaterol (Primary) ; Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 03 Jan 2017 New trial record